HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prell

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble exploring "possible divestiture" of the hair care brand, the company announced May 5. P&G is in the process of seeking bids, but if it does not receive an "acceptable offer," it will retain the brand. "Although Prell is a profitable and highly recognized brand, it is no longer a strategic fit for us," P&G said. In FY 1998 (ended June 30), Prell represented less than 1% of the company's total global beauty care sales. The company plans to focus its resources on its more lucrative brands, such as Pantene Pro-V and Head & Shoulders. If Prell is sold, employees will be transferred to other areas within the company. Investment banking firm Harris Williams (Richmond, Va.) will handle the sale

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel